- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glial phagocytic clearance in Parkinson’s disease ; volume:14 ; number:1 ; day:5 ; month:4 ; year:2019 ; pages:1-14 ; date:12.2019
Molecular neurodegeneration ; 14, Heft 1 (5.4.2019), 1-14, 12.2019
- Urheber
-
Tremblay, Marie-Eve
Cookson, Mark R.
Civiero, Laura
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-019-0314-8
- URN
-
urn:nbn:de:101:1-2019042522424493917912
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
12.04.2025, 00:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tremblay, Marie-Eve
- Cookson, Mark R.
- Civiero, Laura
- SpringerLink (Online service)
Ähnliche Objekte (12)
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson’s disease: a prospective cohort study
The reactions of glial cells in different mouse models of amyotrophic lateral sclerosis and Parkinson’s disease
Characterization of Parkinson’s disease associated DJ-1 mutants and influence of alpha-synuclein on glial cells
Genetic Architecture of Parkinson’s Disease
Molecular pathways to Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson’s disease: a prospective cohort study
The reactions of glial cells in different mouse models of amyotrophic lateral sclerosis and Parkinson’s disease
Characterization of Parkinson’s disease associated DJ-1 mutants and influence of alpha-synuclein on glial cells
Genetic Architecture of Parkinson’s Disease
Molecular pathways to Parkinson’s disease
Mitochondrial dysfunction in Parkinson’s disease
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson’s disease: a prospective cohort study
The reactions of glial cells in different mouse models of amyotrophic lateral sclerosis and Parkinson’s disease
Characterization of Parkinson’s disease associated DJ-1 mutants and influence of alpha-synuclein on glial cells
Genetic Architecture of Parkinson’s Disease
Molecular pathways to Parkinson’s disease